- Home
- CYRX vs TMCI Comparison
CYRX vs TMCI Comparison
Compare CYRX & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYRX
- TMCI
- Stock Information
- Founded
- CYRX 1999
- TMCI 2014
- Country
- CYRX United States
- TMCI United States
- Employees
- CYRX N/A
- TMCI N/A
- Industry
- CYRX Biotechnology: Pharmaceutical Preparations
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CYRX Health Care
- TMCI Health Care
- Exchange
- CYRX Nasdaq
- TMCI Nasdaq
- Market Cap
- CYRX 365.5M
- TMCI 371.1M
- IPO Year
- CYRX N/A
- TMCI 2021
- Fundamental
- Price
- CYRX $7.55
- TMCI $6.00
- Analyst Decision
- CYRX Strong Buy
- TMCI Hold
- Analyst Count
- CYRX 9
- TMCI 6
- Target Price
- CYRX $10.67
- TMCI $9.18
- AVG Volume (30 Days)
- CYRX 554.6K
- TMCI 324.3K
- Earning Date
- CYRX 08-05-2025
- TMCI 08-05-2025
- Dividend Yield
- CYRX N/A
- TMCI N/A
- EPS Growth
- CYRX N/A
- TMCI N/A
- EPS
- CYRX N/A
- TMCI N/A
- Revenue
- CYRX $232,134,000.00
- TMCI $210,819,000.00
- Revenue This Year
- CYRX N/A
- TMCI $10.61
- Revenue Next Year
- CYRX $9.63
- TMCI $10.36
- P/E Ratio
- CYRX N/A
- TMCI N/A
- Revenue Growth
- CYRX 11.75
- TMCI 7.54
- 52 Week Low
- CYRX $4.58
- TMCI $4.54
- 52 Week High
- CYRX $9.78
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- CYRX 59.40
- TMCI 49.03
- Support Level
- CYRX $7.20
- TMCI $6.04
- Resistance Level
- CYRX $7.81
- TMCI $6.44
- Average True Range (ATR)
- CYRX 0.40
- TMCI 0.31
- MACD
- CYRX 0.01
- TMCI 0.06
- Stochastic Oscillator
- CYRX 77.22
- TMCI 59.26
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.